- 专利标题： Use of IL-1ß Binding Antibodies
-
申请号： US15483619申请日： 2017-04-10
-
公开(公告)号： US20170275358A1公开(公告)日： 2017-09-28
- 发明人: Tom Thuren , Andrew Zalewski , Michael Shetzline
- 申请人： Novartis AG
- 主分类号： C07K16/24
- IPC分类号： C07K16/24 ; A61K39/00
摘要：
The present invention relates to an IL-1β binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a recurrent cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered of a qualifying CV event.
公开/授权文献
信息查询
